Found: 42
Select item for more details and to access through your institution.
Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn's Disease: A Pilot Study.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis.
- Published in:
- Inflammation, 2022, v. 45, n. 4, p. 1829, doi. 10.1007/s10753-022-01663-8
- By:
- Publication type:
- Article
Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6325, doi. 10.3390/ijms22126325
- By:
- Publication type:
- Article
Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 10, p. 2203, doi. 10.3390/jcm10102203
- By:
- Publication type:
- Article
Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 5, p. 1323, doi. 10.3390/jcm9051323
- By:
- Publication type:
- Article
Editorial: serum triiodothyronine‐to‐thyroxine (T3/T4) ratio as biomarker of response in IBD ‐ an open issue.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 1, p. 95, doi. 10.1111/apt.16923
- By:
- Publication type:
- Article
Editorial: can serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 2, p. 348, doi. 10.1111/apt.16213
- By:
- Publication type:
- Article
Serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 2, p. 273, doi. 10.1111/apt.16167
- By:
- Publication type:
- Article
Editorial: serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 6, p. 1082, doi. 10.1111/apt.16031
- By:
- Publication type:
- Article
Letter: ustekinumab's effectiveness outcomes compared with vedolizumab in Crohn's disease—what about mucosal healing and biomarkers?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 4, p. 751, doi. 10.1111/apt.15920
- By:
- Publication type:
- Article
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 284, doi. 10.1111/apt.15870
- By:
- Publication type:
- Article
Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique.
- Published in:
- Gastroenterology Research & Practice, 2018, p. 1, doi. 10.1155/2018/2097359
- By:
- Publication type:
- Article
Vegetal and Animal Food Proteins Have a Different Impact in the First Postprandial Hour of Impedance-pH Analysis in Patients with Heartburn.
- Published in:
- Gastroenterology Research & Practice, 2018, p. 1, doi. 10.1155/2018/7572430
- By:
- Publication type:
- Article
Ig Glycosylation in Ulcerative Colitis: It's Time for New Biomarkers.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.654319
- By:
- Publication type:
- Article
Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 6, p. 1539, doi. 10.3390/jcm13061539
- By:
- Publication type:
- Article
Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn's Disease †.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 19, p. 6118, doi. 10.3390/jcm12196118
- By:
- Publication type:
- Article
Treatment and Management of Chronic Inflammatory Bowel Diseases: Optimizing Present and Future Therapeutic Choices.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 18, p. N.PAG, doi. 10.3390/jcm11185267
- By:
- Publication type:
- Article
Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 15, p. 3270, doi. 10.3390/jcm10153270
- By:
- Publication type:
- Article
Inflammatory Bowel Diseases: It's Time for the Adenosine System.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01310
- By:
- Publication type:
- Article
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 7, p. 1296, doi. 10.1111/bcp.14235
- By:
- Publication type:
- Article
Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3824, doi. 10.3390/cancers15153824
- By:
- Publication type:
- Article
Fecal Clostridiales distribution and short‐chain fatty acids reflect bowel habits in irritable bowel syndrome.
- Published in:
- Environmental Microbiology, 2018, v. 20, n. 9, p. 3201, doi. 10.1111/1462-2920.14271
- By:
- Publication type:
- Article
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89790-4
- By:
- Publication type:
- Article
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 11, p. 3440, doi. 10.1111/ene.15607
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study.
- Published in:
- Biomedicines, 2024, v. 12, n. 4, p. 824, doi. 10.3390/biomedicines12040824
- By:
- Publication type:
- Article
Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 12, p. 1845, doi. 10.1093/ecco-jcc/jjac094
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 9, p. 1079, doi. 10.1093/ecco-jcc/jjy076
- By:
- Publication type:
- Article
The complex interplay between gastrointestinal and psychiatric symptoms in irritable bowel syndrome: A longitudinal assessment.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 4, p. 713, doi. 10.1111/jgh.14375
- By:
- Publication type:
- Article
Inflammatory Bowel Diseases: Is There a Role for Nutritional Suggestions?
- Published in:
- Nutrients, 2021, v. 13, n. 4, p. 1387, doi. 10.3390/nu13041387
- By:
- Publication type:
- Article
Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis.
- Published in:
- Nutrients, 2021, v. 13, n. 2, p. 608, doi. 10.3390/nu13020608
- By:
- Publication type:
- Article
Low Fermentable Oligo- Di- and Mono-Saccharides and Polyols (FODMAPs) or Gluten Free Diet: What Is Best for Irritable Bowel Syndrome?
- Published in:
- Nutrients, 2020, v. 12, n. 11, p. 3368, doi. 10.3390/nu12113368
- By:
- Publication type:
- Article
A Low-FODMAP Diet for Irritable Bowel Syndrome: Some Answers to the Doubts from a Long-Term Follow-Up.
- Published in:
- Nutrients, 2020, v. 12, n. 8, p. 2360, doi. 10.3390/nu12082360
- By:
- Publication type:
- Article
Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211023384
- By:
- Publication type:
- Article
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211031420
- By:
- Publication type:
- Article
Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/1756284821999902
- By:
- Publication type:
- Article
Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/1756284820980860
- By:
- Publication type:
- Article
Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211023384
- By:
- Publication type:
- Article
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211031420
- By:
- Publication type:
- Article
Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/1756284820980860
- By:
- Publication type:
- Article